PLK4 and brain cancer: In order to identify improved inhibitors for use in the treatment of brain cancers, it will be important to design compounds that are not only selective for PLK4, but that also have appropriate lipophilicity (logP) and as well as modest total polar surface areas (TPSA) to allow for brain penetration.